Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build

Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions

Example Bundle: ePI document Bundle for Fluenz Tetra nasal spray suspension Package Leaflet for language en

Composition category: Raw
Composition status: final

B. Package Leaflet

unavailable

Package leaflet: Information for the user

Read all of this leaflet carefully before the vaccine is given because it contains important information for you or your child.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor, nurse or pharmacist.
  • This vaccine has been prescribed for you or your child only. Do not pass it on to others.
  • If any of the side effects gets serious, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

What is in this leaflet:

  1. What Fluenz Tetra is and what it is used for
  2. What you need to know before you are given Fluenz Tetra
  3. How Fluenz Tetra is given
  4. Possible side effects
  5. How to store Fluenz Tetra
  6. Contents of the pack and other information

1. What 0 is and what it is used for

Fluenz Tetra is a vaccine to prevent influenza (flu). It is used in children and adolescents 24 months to less than 18 years of age. Fluenz Tetra will help to protect against the four virus strains contained in the vaccine, and other strains closely related to them.

How Fluenz Tetra works

When a person is given the vaccine, the immune system (the body’s natural defence system) will produce its own protection against the influenza virus. None of the ingredients in the vaccine can cause the flu. Fluenz Tetra vaccine viruses are grown in chicken eggs. Each year the vaccine targets four strains of influenza, following the annual recommendations by the World Health Organisation.

2. What you need to know before you take 0

You will not be given Fluenz Tetra:

  • if you are allergic to gentamicin, gelatin or any of the other ingredients of this vaccine (listed in section 6 “Contents of the pack and other information”).
  • if you have ever had a severe allergic reaction to eggs or egg proteins. For signs of allergic reactions, see section 4 “Possible side effects”.
  • if you have a blood disorder or a cancer that affects the immune system.
  • if you have been told by your doctor that you have a weakened immune system as a result of a disease, medicine or other treatment.
  • if you are already taking acetylsalicylic acid (a substance present in many medicines used to relieve pain and lower fever). This is because of the risk of a very rare but serious disease (Reye’s syndrome). If any of these apply, tell your doctor, nurse or pharmacist.

Warnings and precautions

Talk to your doctor, nurse or pharmacist before vaccination:

  • if the child is less than 24 months of age. Children less than 24 months of age should not receive this vaccine because of the risk of side effects.
  • if you have severe asthma or are currently wheezing.
  • if you are in close contact with someone with a severely weakened immune system (for example, a bone marrow transplant patient needing isolation).

If any of these apply, tell your doctor, nurse or pharmacist before vaccination. He or she will decide if Fluenz Tetra is suitable for you.

Other medicines, other vaccines and Fluenz Tetra

Tell your doctor, nurse or pharmacist if the person being vaccinated is taking, has recently taken or might take any other medicines, including medicines that do not require a prescription.

  • Do not give acetylsalicylic acid (a substance present in many medicines used to relieve pain and lower fever) to children for 4 weeks after vaccination with Fluenz Tetra unless your doctor, nurse or pharmacist tells you otherwise. This is because of the risk of Reye’s syndrome, a very rare but serious disease that can affect the brain and liver.
  • It is recommended that Fluenz Tetra is not given at the same time as influenza-specific antiviral medicines, such as oseltamivir and zanamivir. This is because the vaccine may work less effectively.

Your doctor, nurse or pharmacist will decide if Fluenz Tetra can be given at the same time as other vaccines.

Pregnancy and breast-feeding

  • If you are pregnant, think you may be pregnant, plan to become pregnant soon or are breast-feeding, tell your doctor, nurse or pharmacist before receiving this vaccine. Fluenz Tetra is not recommended for women who are pregnant or are breast-feeding.

Driving and using machines

  • Fluenz Tetra has no or negligible influence on the ability to drive and use machines.

3. How to take 0

Fluenz Tetra will be administered under the supervision of a doctor, nurse or pharmacist.

Fluenz Tetra must only be used as a nasal spray.

Fluenz Tetra must not be injected.

Fluenz Tetra will be given as a spray in each nostril. You can breathe normally while you are given Fluenz Tetra. You do not need to actively inhale or sniff.

Dosage

The recommended dose for children and adolescents is 0.2 ml Fluenz Tetra, administered as 0.1 ml in each nostril. Children who have not previously had an influenza vaccine will receive a second, follow-up dose after an interval of at least 4 weeks. Follow your doctor, nurse or pharmacist’s instructions about if and when your child should return for the second dose.

If you have any further questions on this vaccine, ask your doctor, nurse or pharmacist.

4. Possible side effects

Like all medicines, this vaccine can cause side effects, although not everybody gets them. In clinical studies with the vaccine, most side effects were mild in nature and short term.

Ask your doctor, nurse or pharmacist if you want more information about possible side effects from Fluenz Tetra.

Some side effects may be serious

Very rare(may affect up to 1 in 10,000 people):

  • severe allergic reaction: signs of a severe allergic reaction may include shortness of breath and swelling of the face or tongue.

Tell your doctor straight away or seek urgent medical care if you experience any of the effects above.

Other possible side effects of Fluenz TetraVery common(may affect more than 1 in 10 people):

  • runny or stuffy nose
  • reduced appetite
  • weakness

Common(may affect up to 1 in 10 people):

  • fever
  • muscle aches
  • headache

Uncommon(may affect up to 1 in 100 people):

  • rash
  • nose bleed
  • allergic reactions

Reporting of side effects

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store 0

Keep this vaccine out of the sight and reach of children.

Do not use this vaccine after the expiry date which is stated on the applicator label after the letters EXP.

Store in a refrigerator (2°C to 8°C). Do not freeze.

Keep the nasal applicator in the outer carton in order to protect from light.

Before use, the vaccine may be taken out of the refrigerator once for a maximum period of 12 hours at a temperature not above 25°C. If the vaccine has not been used after this 12 hour period, it should be discarded.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Fluenz Tetra contains

The active substances are:

Reassortant influenza virus (live attenuated) of the following four strains*:

A/Victoria/4897/2022 (H1N1)pdm09 - like strainE107.0±0.5 FFU*
(A/Norway/31694/2022, MEDI 369815)
A/Darwin/9/2021 (H3N2) - like strainE107.0±0.5 FFU*
(A/Norway/16606/2021, MEDI 355293)
B/Austria/1359417/2021 - like strainE107.0±0.5 FFU*
(B/Austria/1359417/2021, MEDI 355292)
B/Phuket/3073/2013 - like strainE107.0±0.5 FFU*
(B/Phuket/3073/2013, MEDI 306444)
..................................................................................................................per 0.2 ml dose

* propagated in fertilised hens' eggs from healthy chicken flocks. produced in VERO cells by reverse genetic technology. This product contains genetically modified organisms (GMOs).* fluorescent focus units.

This vaccine complies with the WHO (World Health Organisation) recommendations (Northern Hemisphere) and EU decision for the 2023/2024 season.

The other ingredients are sucrose, dipotassium phosphate, potassium dihydrogen phosphate, gelatin (porcine, Type A), arginine hydrochloride, monosodium glutamate monohydrate and water for injections.

What Fluenz Tetra looks like and contents of the pack

This vaccine is presented as a nasal spray suspension in a single-use nasal applicator (0.2 ml) in a pack size of 1 and 10. Not all pack sizes may be available in your country.

The suspension is colourless to pale yellow, clear to slightly cloudy. Small white particles may be present.

Fluenz Tetra nasal spray suspension

IDS: ft1

Full name: Fluenz Tetra nasal spray suspension

- Invented name part: Fluenz Tetra

- Scientific name part: Reassortant influenza virus* (live attenuated) of four strains

- Strength part:

- Pharmaceutical dose form part: Nasal Spray

Name usage: English (Denmark)


Authorised dose form:

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: active


Product classification:

Package 1 of 2

PMSWI: EU/1/13/887/003

Description:

Marketing status:

Pack size:

Package: 1 Box (Cardboard)

Containing:

Package: 1 Nasal applicator

Containing:

Manufactured Item

Dose form: Nasal spray

Unit of presentation: Spray

Ingredient

Role: Active

Substance: A/Victoria/4897/2022

Ingredient

Role: Active

Substance: A/Darwin/9/2021 (H3N2)

Ingredient

Role: Active

Substance: B/Austria/1359417/2021

Ingredient

Role: Active

Substance: B/Phuket/3073/2013 -

Ingredient

Role: Excipient

Substance: Sucrose

Ingredient

Role: Excipient

Substance: Dipotassium phosphate

Ingredient

Role: Excipient

Substance: Potassium dihydrogen phosphate

Ingredient

Role: Excipient

Substance: Gelatin (porcine, Type A)

Ingredient

Role: Excipient

Substance: Arginine hydrochloride

Ingredient

Role: Excipient

Substance: Monosodium glutamate monohydrate

Ingredient

Role: Excipient

Substance: Water for injections

Package 2 of 2

PMSWI: EU/1/13/887/004

Description:

Marketing status:

Pack size:

Package: 1 Box (Cardboard)

Containing:

Package: 10 Nasal applicator

Containing:

Manufactured Item

Dose form: Nasal spray

Unit of presentation: Spray

Ingredient

Role: Active

Substance: A/Victoria/4897/2022

Ingredient

Role: Active

Substance: A/Darwin/9/2021 (H3N2)

Ingredient

Role: Active

Substance: B/Austria/1359417/2021

Ingredient

Role: Active

Substance: B/Phuket/3073/2013 -

Ingredient

Role: Excipient

Substance: Sucrose

Ingredient

Role: Excipient

Substance: Dipotassium phosphate

Ingredient

Role: Excipient

Substance: Potassium dihydrogen phosphate

Ingredient

Role: Excipient

Substance: Gelatin (porcine, Type A)

Ingredient

Role: Excipient

Substance: Arginine hydrochloride

Ingredient

Role: Excipient

Substance: Monosodium glutamate monohydrate

Ingredient

Role: Excipient

Substance: Water for injections

Administrable Product (1 of 1)

Dose form: Nasal spray

Unit of presentation: Spray

Route of administration:

  • Nasal use

Ingredients:

Ingredient

Role: Active

Substance: A/Victoria/4897/2022

Ingredient

Role: Active

Substance: A/Darwin/9/2021 (H3N2)

Ingredient

Role: Active

Substance: B/Austria/1359417/2021

Ingredient

Role: Active

Substance: B/Phuket/3073/2013 -

Ingredient

Role: Excipient

Substance: Sucrose

Ingredient

Role: Excipient

Substance: Dipotassium phosphate

Ingredient

Role: Excipient

Substance: Potassium dihydrogen phosphate

Ingredient

Role: Excipient

Substance: Gelatin (porcine, Type A)

Ingredient

Role: Excipient

Substance: Arginine hydrochloride

Ingredient

Role: Excipient

Substance: Monosodium glutamate monohydrate

Ingredient

Role: Excipient

Substance: Water for injections